Theriva Biologics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Theriva Biologics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Theriva Biologics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 2.78M shares, a 83.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.78M -14.3M -83.7% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 25.1M +8.09M +47.5% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 17.1M +2.02M +13.4% Mar 21, 2024 10-K 2024-03-25
Q3 2023 17M +1.2M +7.57% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 17M +1.2M +7.57% Aug 2, 2023 10-Q 2023-08-08
Q1 2023 15.1M -143M -90.5% Mar 28, 2023 10-K 2023-03-30
Q3 2022 15.8M -116M -88% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 15.8M -116M -88% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 158M +28.8M +22.2% Mar 16, 2022 10-K 2022-03-16
Q3 2021 132M +112M +560% Nov 3, 2021 10-Q 2021-11-03
Q2 2021 132M +113M +579% Aug 3, 2021 10-Q 2021-08-05
Q1 2021 130M +111M +610% Mar 3, 2021 10-K 2021-03-04
Q3 2020 20M +3.19M +19% Nov 6, 2020 10-Q 2020-11-10
Q2 2020 19.4M +2.63M +15.7% Aug 3, 2020 10-Q 2020-08-06
Q1 2020 18.3M +2.78M +17.9% May 1, 2020 10-Q 2020-05-05
Q3 2019 16.8M +3.32M +24.6% Oct 31, 2019 10-Q 2019-11-04
Q2 2019 16.8M -116M -87.4% Aug 6, 2019 10-Q 2019-08-08
Q1 2019 15.5M -113M -88% Feb 26, 2019 10-K 2019-02-27
Q3 2018 13.5M -115M -89.5% Nov 7, 2018 10-Q 2018-11-08
Q2 2018 133M +4.72M +3.68% Aug 6, 2018 10-Q 2018-08-08
Q1 2018 129M +11M +9.38% May 6, 2018 10-Q 2018-05-08
Q3 2017 129M +36.4M +39.5% Oct 31, 2017 10-Q 2017-11-01
Q2 2017 128M +37M +40.5% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 118M +26.7M +29.4% Feb 28, 2017 10-K 2017-03-02
Q3 2016 92.2M +1.36M +1.5% Oct 28, 2016 10-Q 2016-11-01
Q2 2016 91.3M +2.75M +3.11% Aug 1, 2016 10-Q 2016-08-03
Q1 2016 90.8M +18.1M +24.9% Mar 8, 2016 10-K 2016-03-10
Q3 2015 90.8M +18.3M +25.2% Nov 2, 2015 10-Q 2015-11-05
Q2 2015 88.5M +30.1M +51.4% Aug 6, 2015 10-Q 2015-08-10
Q1 2015 72.7M +14.4M +24.8% Mar 10, 2015 10-K 2015-03-16
Q3 2014 72.5M +27.9M +62.4% Nov 10, 2014 10-Q 2014-11-14
Q2 2014 58.5M +13.8M +30.9% Aug 8, 2014 10-Q 2014-08-14
Q1 2014 58.3M +13.6M +30.5% Mar 27, 2014 10-K 2014-03-31
Q3 2013 44.7M +957K +2.19% Nov 12, 2013 10-Q 2013-11-14
Q2 2013 44.7M +11.3M +33.7% Aug 12, 2013 10-Q 2013-08-14
Q1 2013 44.7M +12M +36.6% Mar 27, 2013 10-K 2013-04-16
Q3 2012 43.7M +15.5M +54.9% Nov 12, 2012 10-Q 2012-11-14
Q2 2012 33.4M +5.27M +18.7% Aug 9, 2012 10-Q/A 2012-09-11
Q1 2012 32.7M Mar 26, 2012 10-K/A 2012-05-11
Q3 2011 28.2M Nov 10, 2011 10-Q 2011-11-14
Q2 2011 28.1M Aug 10, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.